Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE)

被引：0
|
作者：
Kretschmer, Alexander [1 ]
Gleave, Martin E. [2 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Urol, Munich, Germany
[2] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada
来源：
EUROPEAN UROLOGY | 2019年 / 75卷 / 04期
关键词：
THERAPY;
D O I：
10.1016/j.eururo.2018.12.035
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：692 / 693
页数：2
相关论文
共 50 条
  • [31] Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer Data From Patients in the Control Arm of the STAMPEDE Trial
    James, Nicholas D.
    Spears, Melissa R.
    Clarke, Noel W.
    Dearnaley, David P.
    Mason, Malcolm D.
    Parker, Christopher C.
    Ritchie, Alastair W. S.
    Russell, J. Martin
    Schiavone, Francesca
    Attard, Gerhardt
    de Bono, Johann S.
    Birtle, Alison
    Engeler, Daniel S.
    Elliott, Tony
    Matheson, David
    O'Sullivan, Joe
    Pudney, Delia
    Srihari, Narayanan
    Wallace, Jan
    Barber, Jim
    Syndikus, Isabel
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    JAMA ONCOLOGY, 2016, 2 (03) : 348 - 357
  • [32] Primary Tumour Treatment in Patients with Metastatic Prostate Cancer
    Steuber, T.
    Beyer, B.
    AKTUELLE UROLOGIE, 2016, 47 (05) : 388 - 394
  • [33] Prostate radiotherapy in newly-diagnosed metastatic hormone-sensitive prostate cancer: A single-institution experience.
    Morgan, Scott Carlyle
    Holmes, Oliver
    Craig, Julia
    Grimes, Scott
    Eapen, Libni
    Malone, Shawn
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer?
    Choudhury, Ananya
    Chen, Ronald C.
    Henry, Ann
    Mistry, Hitesh
    Mitin, Timur
    Pinkawa, Michael
    Spratt, Daniel E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 33 - 35
  • [35] Differential treatment response of prostate and metastatic lesions in patients with newly diagnosed metastatic prostate cancer.
    Esen, Baris
    Seymen, Hulya
    Falay, Okan
    Tarim, Kayhan
    Kilic, Mert
    Bavbek, Sevil
    Kordan, Yakup
    Tilki, Derya
    Esen, Tarik
    Demirkol, Mehmet Onur
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [36] Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial
    Parker, C. C.
    Sydes, M. R.
    Mason, M. D.
    Clarke, N. W.
    Aebersold, D.
    de Bono, J. S.
    Dearnaley, D. P.
    Ritchie, A. W. S.
    Russell, J. M.
    Thalmann, G.
    Parmar, M. K. B.
    James, N. D.
    CLINICAL ONCOLOGY, 2013, 25 (05) : 318 - 320
  • [37] TRIAL OF ZOLADEX IN NEWLY DIAGNOSED METASTATIC PROSTATE-CANCER PATIENTS
    GRECO, J
    MURPHY, GP
    JOURNAL OF UROLOGY, 1986, 135 (04): : A202 - A202
  • [38] Survival in men with newly diagnosed hormone sensitive metastatic prostate cancer
    Stroomberg, H. V.
    Helgstrand, J. T.
    Brasso, K.
    Roder, A.
    EUROPEAN UROLOGY, 2023, 83
  • [39] Local therapy to the primary tumour for newly diagnosed, oligo-metastatic prostate cancer: A prospective randomized, phase II, open-label trial
    Dai, B.
    Zhang, J.
    Wang, H.
    Wang, Q.
    Kong, Y.
    Zhu, Y.
    Qin, X.
    Lin, G.
    Ye, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S512 - S512
  • [40] Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 195 (02): : 350 - 350
12345